Regulatory Exclusivity: PATENT CHALLENGE
✉ Email this page to a colleague
Drugs with Patent Challenge Regulatory Exclusivity
Click here to exclude patents covering these drugs from this list
Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent No. | Patent Expiration | Exclusivity Expiration | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|
Hikma | MIDAZOLAM IN 0.9% SODIUM CHLORIDE | midazolam | 216159 | Apr 17, 2023 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | PATENT CHALLENGE |
Amneal | SAXAGLIPTIN | saxagliptin hydrochloride | 205941 | Jul 31, 2023 | DISCN | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | PATENT CHALLENGE |
Aurobindo Pharma | SAXAGLIPTIN | saxagliptin hydrochloride | 205972 | Jul 31, 2023 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | PATENT CHALLENGE |
Aurobindo Pharma | PITAVASTATIN CALCIUM | pitavastatin calcium | 206015 | Dec 20, 2016 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | PATENT CHALLENGE |
>Applicant | >Tradename | >Generic Name | >NDA | >Approval Date | >Type | >Patent No. | >Patent Expiration | >Exclusivity Expiration | >Patented / Exclusive Use |